Federal Circuit Again Finds For Janssen On Mental Health Drug Patent
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed a New Jersey federal judge’s finding that two appellant medicine makers failed to show that claims in a patent...To view the full article, register now.
Already a subscriber? Click here to view full article